• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Arthritis News / Do Vitamin D Levels Affect Disease Outcomes in Rheumatoid Arthritis

Do Vitamin D Levels Affect Disease Outcomes in Rheumatoid Arthritis

August 2, 2007 By Arthritis Center

In addition to its role in calcium hemostasis and bone metabolism, vitamin D also appears to be an important regulator of immune function.  However, its role in modulating RA disease activity has not been studied.  Here, Patel et al (Arthritis Rheum 2007; 56(7): 2143) explore the effects of serum vitamin D levels on clinical response in patients with early inflammatory polyarthritis.

Methods

Patients in region of Norfolk, UK with early inflammatory arthritis, defined as having synovitis of 2 or more peripheral joints for at least 4 weeks, were recruited into the Norfolk Arthritis Register (NOAR).  Vitamin D metabolites (25-hydroxy vitamin D (25OH vD) and 1,25-dihydroxy vitamin D (1,25OH2 vD)) were measured at baseline and compared in patients according to clinical features at baseline and outcome at 1 year.

Results

206 Early inflammatory arthritis patients were included.  Two-thirds were women with a mean age of 59 years.  At baseline, 35% of patients fulfilled ACR classification criteria for RA, while 45% fulfilled these criteria at 1 year.
At baseline, subjects fulfilling ACR criteria for RA had significantly lower mean 1,25OH2 vD levels compared to those who did not meet RA criteria.  For 25OH vD, a trend to lower levels was observed for subjects who did and did not fulfill ACR criteria (p=0.06).  In regression models of baseline data, each 10 ng/mL increase in 25OH vD was associated with a 42.7% lower tender joint count, a 25% lower CRP, a 0.30 lower DAS28 score, and a 39% lower odds of being in the higher HAQ group.  Each 10 pg/mL increase in 1,25OH2 vD was associated with a 21% lower odds of being in the higher HAQ group.
At 1 year, baseline 25OH and 1,25OH2 levels were both significantly lower in subjects fulfilling ACR criteria for RA.  In regression models, each 10 ng/mL increase in baseline 25OH vD was associated with a 46.3% decrease in tender joint count at 1 year and a 41% lower odds of being in the higher HAQ group.  Each 10 pg/mL increase in baseline 1,25OH2 vD was associated with a 26% lower odds of being in the higher HAQ group.  Findings were similar in analyses adjusted for DMARD use of the first year.

Conclusions

Lower levels of vitamin D metabolites were associated with clinical outcomes in patients with early inflammatory polyarthritis.

Editorial Comment

These are interesting findings that bring to light the possible role of vitamin D in the modulation of RA disease symptoms and activity.  A previous study identified an association between low vitamin D levels and incident RA (Merlino Arthritis Rheum 2004; 50; 72) .  This study suggests that the dangers of low vitamin D may extend beyond the initiation of disease and affect whether inflammatory arthritis develops into a fully fledged RA phenotype.  It is important to note that clinically defined “Hypovitaminosis D” is very common (particularly in this cohort deriving from the UK with its preponderance of cloudy days) and that more than 75% of the cohort presented here would meet criteria for vitamin D deficiency (25OH vD < 30 ng/mL).  Thus, it would be interesting to see if these findings were more robust in a cohort in which higher vitamin D levels were more prevalent.  The findings that low vitamin D levels were more associated with tender joints and HAQ, but not swollen joints could suggest that vitamin D may affect pain perception rather than act as an immunomodulator.  However, these effects are difficult to parse out given the overlaps in standard clinical assessment tools in RA.  Although vitamin D supplementation is warranted in patients with low levels, it is not clear from this or available studies whether supplementation with vitamin D replacement can alter disease outcomes in RA.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Use of this Site

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Recent News

Exercise Tips for Arthritis Patients

How Does Exercise Affect my Joints? How Frequently Should I Be Exercising? Should I Lose Weight for Exercise to be

Risks and Benefits of Biologic Medications

Victoria Ruffing, RN, BC, Director of Patient Education at the Johns Hopkins Arthritis Center, shares the risks and benefits of biologic for

How to Manage Rheumatoid Arthritis Flares

Through research, doctors have a clearer understanding of how flares can impact a patient on a personal and emotional level. Dr. Uzma Haque

Complementary & Alternative Medicines for Psoriatic Arthritis

There are many complementary & alternative medicines and practices that have been found to be beneficial in curbing arthritis pain,

I can’t be a runner because I have Rheumatoid Arthritis (RA), right?

Dr. Manno discusses running and Rheumatoid Arthritis. Is it an option for the RA patient?

News Categories

  • Ankylosing Spondylitis News
  • Fibromyalgia News
  • Gout News
  • Lupus News
  • Osteoarthritis News
  • Osteoporosis News
  • Psoriatic Arthritis News
  • Rheumatoid Arthritis News
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy